HHS Secretary Robert F. Kennedy Jr. visits Tennessee, pledges drug‑price cuts, AI fraud fights and rural health funding On a Tennessee visit, HHS Secretary Robert F. Kennedy Jr. outlined federal steps he said will lower drug prices, expand rural health funding and use AI to detect Medicare/Medicaid fraud; he also previewed an April report on baby‑formula contaminants and urged diet-based prevention strategies for child health.

HHS Secretary Robert F. Kennedy Jr. is taking bold steps to tackle rising drug costs and chronic health issues, promising lower prices and innovative AI solutions for Medicare fraud.

Click to read more!

#TN #TennesseeHealth #CitizenPortal #DrugPriceTransparency #RuralHealthCare

Administration says most-favored-nation agreements will sharply lower U.S. drug prices At a Cabinet meeting the president announced what he called a most-favored-nation policy and said drugmakers agreed to prices that will cut many U.S. prescription costs; the Health official present said 16 of 17 companies have reached agreements and rural health funding will support access.

The president's new "most-favored-nation" policy promises to slash U.S. drug prices to the lowest rates globally, with major pharmaceutical companies on board.

Get the details!

#US #DrugPriceTransparency #PharmaceuticalReform #RuralHealthAccess #USHealth #CitizenPortal

Prescription Drug Affordability Board briefs Finance Committee on cost reviews, WACC penalty and potential price limits Dr. Andy York told the Finance Committee on Jan. 15 that the board has completed preliminary affordability determinations for two diabetes drugs and has recommended policy options — including an incentive to curb list‑price growth and plans to pursue upper payment limits — with final actions expected after public methodology review this spring.

Maryland's Prescription Drug Affordability Board is taking bold steps to cap soaring prices on diabetes medications, aiming to ease the financial burden on patients.

Click to read more!

#MD #PublicPolicyReform #HealthcareAccess #DrugPriceTransparency #CitizenPortal #MarylandPrescriptionDrugs

Oregon drug pricing transparency law survives constitutional challenge, US appeals court says A U.S. appeals court said Tuesday that an Oregon law meant to increase transparency for prescription drug prices is constitutional, turning away a challenge brought by a pharmaceutical industry group.

Great news for Oregon patients! Our Drug Price Transparency Law is an important step toward holding Big Pharma accountable for their price gouging!

www.reuters.com/legal/govern...

#Oregon #DrugPriceTransparency #Orpol #BigPharma #OCAP #HealthPolicySky